Skip to content

PAQUES PHARMA

Active Private limited companyfounded 2005active for 21 yearsChaussée de Dinant 11, 5170 ProfondevilleKBO/BCE: BE 0874.668.893

Timeline

29 events since 2005

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBabbreviated format · 3 days before the deadline
2025
Annual accounts 2024 filed PDFfull format · 1 day before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0874668893
2024
Annual accounts 2023 filed PDFfull format · 22 days late
2023
Resignation: (director)Reappointment: (director) · Director discharge: · Name clause: PAQUES PHARMA · General meeting of 20-06-202310 points ▸
  • Director resignation,
  • Director reappointment, (director (not named in the articles))
  • Director discharge,
  • Registered office clause, chaussée de Dinant 11, 5170 Profondeville
  • Name clause, PAQUES PHARMA
  • is a shareholder
  • is a shareholder
  • General meeting, 20-06-2023
  • Legal-form conversion, from private limited company (pre-2019) to private limited company
  • 500 shares
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFfull format · 39 days before the deadline
2022
Highest result from 2006 to 2025 net €105,834 ▲5.8% The operating result of €157,671 and the net result of €105,834 are both a record.
Equity above €500,000 equity €515,687 ▲21.2% Equity rises from €425,652 to €515,687.
Annual accounts 2021 filed PDFfull format · 52 days before the deadline
2021
Annual accounts 2020 filed PDFfull format · 53 days before the deadline
2020
Annual accounts 2019 filed PDFfull format · 53 days before the deadline
2019
Annual accounts 2018 filed PDFfull format · 37 days before the deadline
2018
Annual accounts 2017 filed PDFfull format · 15 days before the deadline
2017
Equity above €200,000 equity €219,035 ▲21.2% Equity rises from €180,793 to €219,035.
Annual accounts 2016 filed PDFfull format · 12 days before the deadline
2016
Equity above €150,000 equity €180,793 ▲80.9% Equity rises from €99,942 to €180,793.
Annual accounts 2015 filed PDFfull format · 25 days late
2015
Annual accounts 2014 filed PDFfull format · 30 days before the deadline
2014
Annual accounts 2013 filed PDFfull format · 15 days before the deadline
2013
Annual accounts 2012 filed PDFfull format · 28 days before the deadline
2012
Weakest financial year net €26,522 ▼29.7% The net result drops to €26,522, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2011 filed PDFfull format · 28 days before the deadline
2011
Annual accounts 2010 filed PDFfull format · 46 days before the deadline
2010
Annual accounts 2009 filed PDFfull format · 32 days before the deadline
2009
Annual accounts 2008 filed PDFfull format · 31 days before the deadline
2008
Annual accounts 2007 filed PDFfull format · 31 days before the deadline
2007
Annual accounts 2006 filed PDFfull format · 28 days before the deadline
2005
Incorporation PDFpublished on 04-07-2005
First establishment Chaussée de Dinant 11, Profondeville

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

PAQUES PHARMA was incorporated on 24 June 2005.1 Total assets fell from €952,517 in 2018 to €797,673 in 2025 and headcount from 2.1 to 2.1 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Next steps